Norgine Launches ENDOCUFF VISION® in Belgium, Netherlands and France

LONDON, May 12, 2016 /PRNewswire/ --

ENDOCUFF VISION(R) designed to improve visualisation of the colon 

Norgine B.V. today announced that ENDOCUFF VISION(R) is now available in Belgium, Netherlands and France. ENDOCUFF VISION(R) is a Class 1 sterile medical device attached to the end of the colonoscope that opens up the field of view by retracting folds during withdrawal. It is proven to help increase the detection of pre-cancerous polyps as part of bowel cancer screening.

(Logo: )

Colorectal cancer is the second most common cause of cancer-related mortality in the world [1], with nearly 1.4 million new cases diagnosed worldwide and 412,000 people in Europe.[2],[3] The detection and removal of pre-cancerous adenomas during colonoscopy substantially reduces both the development of and death from colorectal cancer.[4]

Peter Martin, Chief Operating Officer, Norgine, commented "We are pleased to announce the launch of ENDOCUFF VISION(R) in these additional markets. ENDOCUFF VISION(R) is a new device that is proven to improve visualisation of the colon, thus increasing the detection of cancerous and precancerous cells. By doing so it helps patients and healthcare systems by allowing the prevention and treatment of colon cancer at an earlier stage than might otherwise be possible."

Over the years, Norgine has strengthened its colon cancer prevention and detection portfolio to ensure quality in colonoscopy and ultimately enhance health outcomes for patients.

In Europe, Australia and New Zealand, ENDOCUFF VISION(R) is available through Norgine's infrastructure including: Australia, Austria, Belgium, Finland, France, Denmark, Germany, Italy, Ireland, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland and the UK.

In the US and Canada, ENDOCUFF VISION(R) is available through Olympus Corporation of the Americas.

To see how ENDOCUFF VISION(R) works click here [ ]  

To view the full press release go to  

Follow us @norgine 

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al.  Cancer incidence and mortality patterns in Europe:  Estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-1403

2. Colorectal Cancer Statistics, World Cancer Research Fund International, [Accessed 9 May 2015]

3. Zavoral M et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009;15(47):5907-5915

4. LeClercq CMC, Bouwens MWE, Rondagh, EJA et al. Postcolonoscopy colorectal cancers are preventable: a population-based study.  Gut 2014;63:957-963 Media Contacts: 

Isabelle Jouin, T: +44(0)1895-453643

Charlotte Andrews, T: +44(0)1895-453607


Norgine B.V.

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen